☆ 4.3 Review

Enhancing radiotherapy outcomes in rectal cancer: A systematic review of targeting hypoxia-induced radioresistance

CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY (2024)

Related references

Note: Only part of the references are listed.

Article Cell Biology

Functional crosstalk between chromatin and hypoxia signalling

Harry Collier et al.

Summary: Chromatin, consisting of DNA and histone proteins, plays a crucial role in regulating gene expression. Recent studies have revealed the intricate connection between chromatin and oxygen, particularly in the context of hypoxia. This review focuses on the mechanisms that control chromatin in hypoxia, including histone modifications, chromatin remodellers, and their integration with hypoxia inducible factors.

CELLULAR SIGNALLING (2023)

Add to Collection

Article Multidisciplinary Sciences

Identification of a hypoxia-related gene prognostic signature in colorectal cancer based on bulk and single-cell RNA-seq

Yihuan Qiao et al.

Scientific Reports (2023)

Add to Collection

Review Biochemistry & Molecular Biology

DNA damage and repair dependencies of ionising radiation modalities

Emma Melia et al.

Summary: Radiotherapy is an important treatment for cancer, and particle radiotherapy offers advantages over conventional photons. Proton beam therapy and carbon ion radiotherapy can precisely target tumors and generate enhanced therapeutic responses. DNA damage plays a key role in tumor cell killing, and the complexity of DNA damage increases with radiation intensity. Understanding the DNA repair pathways activated by different radiation sources is crucial for improving the efficacy of radiotherapy.

BIOSCIENCE REPORTS (2023)

Add to Collection

Article Oncology

Proton Tumor Control Relative Biological Effectiveness (RBE) Estimated for Various Fractionation Schedules and Hypoxia Levels

J. Jeong et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2022)

Add to Collection

Review Oncology

Overcoming the Impact of Hypoxia in Driving Radiotherapy Resistance in Head and Neck Squamous Cell Carcinoma

Rhianna M. Hill et al.

Summary: Hypoxia, a common phenomenon in tumors, leads to increased resistance to radiotherapy and poor prognosis for patients. Overcoming hypoxia within tumors by developing new therapeutic techniques in combination with radiotherapy is crucial for improving patient survival. This review provides an up-to-date overview of how hypoxia contributes to radioresistance in head and neck cancer and discusses strategies to overcome this challenge.

CANCERS (2022)

Add to Collection

Review Gastroenterology & Hepatology

The measurement and modification of hypoxia in colorectal cancer: overlooked but not forgotten

Teddy Fletcher et al.

Summary: Tumour hypoxia is a common consequence of rapid tumor growth and inadequate blood vessel development. It inhibits various treatment methods and leads to poorer clinical outcomes in colorectal cancer. This review focuses on the knowledge and evidence regarding the measurement and modification of hypoxia in CRC. The role of hypoxia, evidence of its existence, its correlation with poor oncological outcome, the potential of hypoxic modification, the prognostic and monitoring implications, and the imaging tools and technologies for measuring CRC hypoxia are discussed.

GASTROENTEROLOGY REPORT (2022)

Add to Collection

Review Oncology

Predicting response to neoadjuvant chemoradiotherapy in rectal cancer: from biomarkers to tumor models

Moying Li et al.

Summary: Colorectal cancer is a major global contributor to cancer-related morbidity, with over one-third of cases located in the rectum. Neoadjuvant chemoradiotherapy followed by surgical resection is commonly used for locally advanced rectal cancer. This review summarizes current and novel concepts in neoadjuvant therapy for rectal cancer, discusses potential predictive biomarkers, and explores recent advances in biomarker discovery from clinical, histopathological, and molecular perspectives. The role of emerging predictive biomarkers from the tumor environment, such as immune cell composition and gut microbiome, is also presented.

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2022)

Add to Collection

Review Oncology

Metformin as a radiosensitiser for pelvic malignancy: A systematic review of the literature

R. E. Clifford et al.

Summary: Recent studies have shown that metformin can reduce cell viability post-radiotherapy in rectal and prostate cancer cell lines, with an enhanced effect in tumors with a p53 mutation, and increased apoptosis post-radiotherapy for cervical cancer. Clinical trials also demonstrate improved tumor and nodal downstaging and pCR rates for rectal cancer using metformin as a radiosensitizer. Further prospective studies are needed to assess the routine use of metformin on cancer-related outcomes.

EJSO (2021)

Add to Collection

Article Oncology

Selectively Targeting Tumor Hypoxia With the Hypoxia-Activated Prodrug CP-506

Alexander M. A. van der Wiel et al.

Summary: Hypoxia-activated prodrugs (HAP), such as CP-506, have shown promise in selectively targeting hypoxic tumor cells and demonstrating broad antitumor activity. The study revealed that tumor hypoxia and cellular sensitivity to CP-506 are strong determinants of the drug's antitumor effects.

MOLECULAR CANCER THERAPEUTICS (2021)

Add to Collection

Article Oncology

Investigating the potential of proton therapy for hypoxia-targeted dose escalation in non-small cell lung cancer

Andreas Koethe et al.

Summary: This study investigates the potential of proton therapy for patient-specific dose escalation in lung cancer treatment, showing that proton therapy can improve treatment outcomes and reduce side effects on normal tissues compared to conventional photon techniques.

RADIATION ONCOLOGY (2021)

Add to Collection

Review Oncology

Angiogenesis Inhibitors for Colorectal Cancer. A Review of the Clinical Data

Torben Frostrup Hansen et al.

Summary: Angiogenesis is a key element in the treatment strategy for colorectal cancer, with challenges in finding effective biomarkers and personalized treatments. The combination of immunotherapy and anti-angiogenic treatment brings new hope for patients.

CANCERS (2021)

Add to Collection

Review Medicine, Research & Experimental

A Review of the Role of Hypoxia in Radioresistance in Cancer Therapy

Wafa Bouleftour et al.

Summary: Hypoxia is a crucial factor in tumor cells and a barrier in cancer treatment. Various strategies have been developed to overcome hypoxia-induced radioresistance, but they have shown limited efficacy and may lead to adverse effects.

MEDICAL SCIENCE MONITOR (2021)

Add to Collection

Review Biochemistry & Molecular Biology

Role of Hypoxia in the Control of the Cell Cycle

Jimena Druker et al.

Summary: The cell cycle is a crucial cellular process for genome replication, with mechanisms needed to respond to stress signals like hypoxia. This review discusses the interplay between transcriptional and post-transcriptional mechanisms initiated under hypoxia and cell cycle control. Overall, the relationship between the cellular response to hypoxia and the cell cycle ensures survival and minimizes errors during cell division.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Add to Collection

Review Oncology

Proton beam therapy in rectal cancer: A systematic review and meta-analysis

Matthew Fok et al.

Summary: Comparative analysis between proton beam therapy and conventional photon-based radiotherapy in the treatment of locally advanced rectal cancer showed that proton beam therapy can significantly reduce irradiation to organs at risk, potentially leading to better outcomes in terms of oncological results.

SURGICAL ONCOLOGY-OXFORD (2021)

Add to Collection

Article Cell Biology

Prognostic value of a hypoxia-related microRNA signature in patients with colorectal cancer

Yongmei Yang et al.

AGING-US (2020)

Add to Collection

Review Oncology

Hypoxia PET Imaging with [18F]-HX4-A Promising Next-Generation Tracer

Sebastian Sanduleanu et al.

CANCERS (2020)

Add to Collection

Article Multidisciplinary Sciences

Histone demethylase KDM6A directly senses oxygen to control chromatin and cell fate

Abhishek A. Chakraborty et al.

SCIENCE (2019)

Add to Collection

Article Multidisciplinary Sciences

Hypoxia induces rapid changes to histone methylation and reprograms chromatin

Michael Batie et al.

SCIENCE (2019)

Add to Collection

Article Oncology

Atovaquone: An Antiprotozoal Drug Suppresses Primary and Resistant Breast Tumor Growth by Inhibiting HER2/β-Catenin Signaling

Nehal Gupta et al.

MOLECULAR CANCER THERAPEUTICS (2019)

Add to Collection

Review Gastroenterology & Hepatology

Neoadjuvant radiotherapy for rectal cancer management

Gerard Feeney et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2019)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

Effects of metformin on tumor hypoxia and radiotherapy efficacy: a [18F]HX4 PET imaging study in colorectal cancer xenografts

Sven De Bruycker et al.

EJNMMI RESEARCH (2019)

Add to Collection

Review Biochemistry & Molecular Biology

Role of hypoxia in cancer therapy by regulating the tumor microenvironment

Xinming Jing et al.

MOLECULAR CANCER (2019)

Add to Collection

Article Oncology

Autophagy induced by ionizing radiation promotes cell death over survival in human colorectal cancer cells

Fabian Classen et al.

EXPERIMENTAL CELL RESEARCH (2019)

Add to Collection

Article Oncology

Administration of Hypoxia-Activated Prodrug Evofosfamide after Conventional Adjuvant Therapy Enhances Therapeutic Outcome and Targets Cancer-Initiating Cells in Preclinical Models of Colorectal Cancer

Jennifer Haynes et al.

CLINICAL CANCER RESEARCH (2018)

Add to Collection

Article Chemistry, Medicinal

Next-Generation Hypoxic Cell Radiosensitizers: Nitroimidazole Alkylsulfonamides

Muriel Bonnet et al.

JOURNAL OF MEDICINAL CHEMISTRY (2018)

Add to Collection

Review Biotechnology & Applied Microbiology

The role of HIF-1α in chemo-/radioresistant tumors

Yu Xia et al.

ONCOTARGETS AND THERAPY (2018)

Add to Collection

Article Pharmacology & Pharmacy

Antidiabetic Biguanides Radiosensitize Hypoxic Colorectal Cancer Cells Through a Decrease in Oxygen Consumption

Sven de Mey et al.

FRONTIERS IN PHARMACOLOGY (2018)

Add to Collection

Article Oncology

Fructose-bisphosphate aldolase A is a key regulator of hypoxic adaptation in colorectal cancer cells and involved in treatment resistance and poor prognosis

Kenji Kawai et al.

INTERNATIONAL JOURNAL OF ONCOLOGY (2017)

Add to Collection

Article Oncology

Vorinostat suppresses hypoxia signaling by modulating nuclear translocation of hypoxia inducible factor 1 alpha

Chao Zhang et al.

ONCOTARGET (2017)

Add to Collection

Review Biochemistry & Molecular Biology

Hypoxia and Inflammation in Cancer, Focus on HIF and NF-κB

Laura D'Ignazio et al.

BIOMEDICINES (2017)

Add to Collection

Article Multidisciplinary Sciences

The anti-malarial atovaquone increases radiosensitivity by alleviating tumour hypoxia

Thomas M. Ashton et al.

NATURE COMMUNICATIONS (2016)

Add to Collection

Article Oncology

Role of Autophagy as a Survival Mechanism for Hypoxic Cells in Tumors

Qian Tan et al.

NEOPLASIA (2016)

Add to Collection

Article Oncology

Hypoxia-induced autophagy reduces. radiosensitivity by the HIF-1α/miR-210/Bcl-2 pathway in colon cancer cells

Yong Sun et al.

INTERNATIONAL JOURNAL OF ONCOLOGY (2015)

Add to Collection

Article Oncology

Anti-VEGF antibody therapy induces tumor hypoxia and stanniocalcin 2 expression and potentiates growth of human colon cancer xenografts

Shinichiro Miyazaki et al.

INTERNATIONAL JOURNAL OF CANCER (2014)

Add to Collection

Review Oncology

Histone deacetylase inhibitors as radiosensitisers: effects on DNA damage signalling and repair

B. Groselj et al.

BRITISH JOURNAL OF CANCER (2013)

Add to Collection

Article Multidisciplinary Sciences

The Pro-Survival Role of Autophagy Depends on Bcl-2 Under Nutrition Stress Conditions

Hai-Dong Xu et al.

PLOS ONE (2013)

Add to Collection

Review Cell Biology

Chromatin as an oxygen sensor and active player in the hypoxia response

Andrew Melvin et al.

CELLULAR SIGNALLING (2012)

Add to Collection

Article Oncology

Radiosensitization by the histone deacetylase inhibitor vorinostat under hypoxia and with capecitabine in experimental colorectal carcinoma

Marie Gron Saelen et al.

RADIATION ONCOLOGY (2012)

Add to Collection

Article Cell Biology

Regulation of the Autophagic Bcl-2/Beclin 1 Interaction

Jean-Paul Decuypere et al.

Cells (2012)

Add to Collection

Review Oncology

Targeting hypoxia in cancer therapy

William R. Wilson et al.

NATURE REVIEWS CANCER (2011)

Add to Collection

Review Oncology

Autophagy: cellular and molecular mechanisms

Danielle Glick et al.

JOURNAL OF PATHOLOGY (2010)

Add to Collection

Review Oncology

BIOMARKERS FOR RESPONSE TO NEOADJUVANT CHEMORADIATION FOR RECTAL CANCER

Jeffrey G. Kuremsky et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2009)

Add to Collection

Article Gastroenterology & Hepatology

Tumor Hypoxia Detected by Positron Emission Tomography with 60Cu-ATSM as a Predictor of Response and Survival in Patients Undergoing Neoadjuvant Chemoradiotherapy for Rectal Carcinoma: A Pilot Study

David W. Dietz et al.

DISEASES OF THE COLON & RECTUM (2008)

Add to Collection

Article Biochemistry & Molecular Biology

Chromatin dynamics during DSB repair

Martin Falk et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2007)

Add to Collection

Review Oncology

Hypoxia in cancer: significance and impact on clinical outcome

Peter Vaupel et al.

CANCER AND METASTASIS REVIEWS (2007)

Add to Collection

Article Oncology

Histone deacetylase inhibitors radiosensitize human melanoma cells by suppressing DNA repair activity

A Munshi et al.

CLINICAL CANCER RESEARCH (2005)

Add to Collection

Review Oncology

Targeting HIF-1 for cancer therapy

GL Semenza

NATURE REVIEWS CANCER (2003)

Add to Collection

Review Oncology

Prognostic significance of tumor oxygenation in humans

SM Evans et al.

CANCER LETTERS (2003)

Add to Collection

Review Microbiology

Antiparasitic agent atovaquone

AL Baggish et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)

Add to Collection

© Peeref 2019-2024. All rights reserved.